|
1
|
Qi X, Varma P, Newman D and Dorian P: Gap
junction blockers decrease defibrillation thresholds without
changes in ventricular refractoriness in isolated rabbit hearts.
Circulation. 104:1544–1549. 2001. View Article : Google Scholar
|
|
2
|
Moreno AP, Rook MB, Fishman GI and Spray
DC: Gap junction channels: distinct voltage-sensitive and
-insensitive conductance states. Biophys J. 67:113–119. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yu ZB and Sheng JJ: Remodeling of cardiac
gap junctions and arrhythmias. Acta Physiologica Sinica.
63:586–592. 2011.(In Chinese).
|
|
4
|
Delmar M and Makita N: Cardiac connexins,
mutations and arrhythmias. Curr Opin Cardiol. 27:236–241. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Palatinus JA, Rhett JM and Gourdie RG: The
connexin43 carboxyl terminus and cardiac gap junction organization.
Biochim Biophys Acta. 1818:1831–1843. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Severs NJ, Bruce AF, Dupont E and Rothery
S: Remodelling of gap junctions and connexin expression in diseased
myocardium. Cardiovasc Res. 80:9–19. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dupont E, Matsushita T, Kaba RA, et al:
Altered connexin expression in human congestive heart failure. J
Mol Cell Cardiol. 33:359–371. 2001. View Article : Google Scholar
|
|
8
|
Ohara T, Qu Z, Lee MH, et al: Increased
vulnerability to inducible atrial fibrillation caused by partial
cellular uncoupling with heptanol. Am J Physiol Heart Circ Physiol.
283:H1116–H1120. 2002.PubMed/NCBI
|
|
9
|
Tse G, Hothi SS, Grace AA and Huang CL:
Ventricular arrhythmogenesis following slowed conduction in
heptanol-treated, Langendorff-perfused mouse hearts. J Physiol Sci.
62:79–92. 2012. View Article : Google Scholar
|
|
10
|
Dorian P, Wang M, David I and Feindel C:
Oral clofilium produces sustained lowering of defibrillation energy
requirements in a canine model. Circulation. 83:614–621. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Labhasetwar V, Underwood T, Heil RW Jr, et
al: Epicardial administration of ibutilide from polyurethane
matrices: effects on defibrillation threshold and
electrophysiologic parameters. J Cardiovasc Pharmacol. 24:826–840.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Saffitz JE, Green KG, Kraft WJ, et al:
Effects of diminished expression of connexin 43 on gap junction
number and size in ventricular myocardium. Am J Physiol Heart Circ
Physiol. 278:H1662–H1670. 2000.PubMed/NCBI
|
|
13
|
Kwong KF, Schuessler RB, Green KG, et al:
Differential expression of gap junction proteins in the canine
sinus node. Circ Res. 82:604–612. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Y, Xue Q, Ma J, et al: Effects of
imidapril on heterogeneity of action potential and calcium current
of ventricular myocytes in infarcted rabbits. Acta Pharmacol Sin.
25:1458–1463. 2004.PubMed/NCBI
|
|
15
|
Saffitz JE and Kléber AG: Gap junctions,
slow conduction, and ventricular tachycardia after myocardial
infarction. J Am Coll Cardiol. 60:1111–1113. 2012.PubMed/NCBI
|
|
16
|
Callans DJ, Moore EN and Spear JF: Effect
of coronary perfusion of heptanol on conduction and ventricular
arrhythmias in infarcted canine myocardium. J Cardiovasc
Electrophysiol. 7:1159–1171. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li F, Sugishita K, Su Z, et al: Activation
of connexin-43 hemichannels can elevate [Ca2+]i and
[Na+]i in rabbit ventricular myocytes during metabolic
inhibition. J Mol Cell Cardiol. 33:2145–2155. 2001.PubMed/NCBI
|
|
18
|
Sánchez JA, Rodríguez-Sinovas A,
Fernández-Sanz C, et al: Effects of a reduction in the number of
gap junction channels or in their conductance on
ischemia-reperfusion arrhythmias in isolated mouse hearts. Am J
Physiol Heart Circ Physiol. 301:H2442–2453. 2011.
|
|
19
|
Wit AL and Peters NS: The role of gap
junctions in the arrhythmias of ischemia and infarction. Heart
Rhythm. 9:308–311. 2012. View Article : Google Scholar : PubMed/NCBI
|
